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Abstract
Aims/hypothesis The aim of this study was to examine the
prospective associations between objectively measured physi-
cal activity energy expenditure (PAEE), sedentary time,
moderate-to-vigorous-intensity physical activity (MVPA), car-
diorespiratory fitness (CRF) and cardiometabolic risk factors
over 4 years in individuals with recently diagnosed diabetes.
Methods Among 308 adults (mean age 61.0 [SD 7.2]
years; 34% female) with type 2 diabetes from the
Anglo–Danish–Dutch Study of Intensive Treatment in
People with Screen Detected Diabetes in Primary Care
(ADDITION)-Plus study, wemeasured physical activity using
individually calibrated combined heart rate and movement
sensing. Multivariable linear regression models were con-
structed to examine the associations between baseline PAEE,
sedentary time, MVPA, CRF and cardiometabolic risk factors
and clustered cardiometabolic risk (CCMR) at follow-up, and
change in these exposures and change in CCMR and its com-
ponents over 4 years of follow-up.
Results Individuals who increased their PAEE between base-
line and follow-up had a greater reduction in waist circumfer-
ence (−2.84 cm, 95% CI −4.84, −0.85) and CCMR (−0.17,
95% CI −0.29, −0.04) compared with those who decreased
their PAEE. Compared with individuals who decreased their
sedentary time, those who increased their sedentary time had a
greater increase in waist circumference (3.20 cm, 95% CI 0.84,
5.56). Increases in MVPA were associated with reductions in
systolic blood pressure (−6.30 mmHg, 95% CI −11.58, −1.03),
while increases in CRF were associated with reductions in
CCMR (−0.23, 95% CI −0.40,−0.05) and waist circumference
(−3.79 cm, 95% CI −6.62, −0.96). Baseline measures were
generally not predictive of cardiometabolic risk at follow-up.
Conclusions/interpretation Encouraging people with recently
diagnosed diabetes to increase their physical activity and
decrease their sedentary time may have beneficial effects on
their waist circumference, blood pressure and CCMR.
Keywords Cardiometabolic . Cardiovascular . Diabetes .
Fitness . Intervention . Physical activity . Prospective .
Sedentary
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Introduction
Individuals with type 2 diabetes are at increased risk of devel-
oping cardiovascular disease (CVD) and have poorer survival
rates after diagnosis of CVD in comparison with those without
diabetes [1–3]. Although physical inactivity is an important
and well-established cardiometabolic risk factor [4, 5], indi-
viduals with diabetes are less likely to meet current physical
activity guidelines [6, 7] compared with the general adult
population.
In addition to the health benefits associated with increasing
physical activity, recent research suggests that limiting the
amount of time spent sedentary may also improve cardiomet-
abolic health [8]. Several studies have demonstrated positive
associations between objectively measured time spent seden-
tary and poor cardiometabolic outcomes, independent of
moderate-to-vigorous-intensity physical activity (MVPA) in
healthy adult populations [9–12]. Similarly, inverse associa-
tions between MVPA and cardiometabolic risk have been
reported, independent of the time spent sedentary [13, 14].
Furthermore, while it is known that increases in physical
activity are associated with increases in cardiorespiratory fit-
ness (CRF), we have previously shown that the beneficial
association between physical activity energy expenditure
(PAEE; the energy expended above that required when rest-
ing) and metabolic risk factors is independent of CRF [15].
This is important because it means that increases in PAEE,
even when below the level required to improve CRF, can still
lead to important improvements in cardiometabolic health.
To our knowledge, no studies have examined the prospec-
tive association between CRF or objectively measured seden-
tary time and physical activity and metabolic risk among
individuals with diabetes. Moreover, as studies have generally
examined the associations between physical activity and car-
diometabolic health cross-sectionally, the ability to infer the
direction of these associations is limited.
Using data from the Anglo–Danish–Dutch Study of
Intensive Treatment in People with Screen Detected
Diabetes in Primary Care (ADDITION)-Plus study, we exam-
ined: (1) whether baseline objectively measured PAEE, sed-
entary time, MVPA and CRF were associated with cardiomet-
abolic risk at 4 year follow-up; and (2) whether changes in
these exposures were associated with changes in cardiometa-
bolic risk over 4 years.
Methods
Study design and population The rationale and design of the
ADDITION-Plus study has previously been reported [16].
Briefly, ADDITION-Plus is an explanatory randomised con-
trolled trial of a facilitator-led, theory-based behaviour change
intervention tailored to individuals with recently diagnosed
diabetes. Participants were recruited from 34 general practice
clinics in East Anglia, UK. Eligible individuals were aged
40–69 years with screen-detected diabetes diagnosed through
the ADDITION-Cambridge study [17] or clinically diagnosed
in the previous 3 years. Women who were pregnant or lactat-
ing were excluded, as were individuals with a psychotic ill-
ness or a likely survival prognosis of less than 1 year.
Of the 1,109 eligible participants, 478 agreed to participate
and were individually randomised to receive either intensive
treatment alone (n=239) or intensive treatment plus a
facilitator-led individual behaviour change intervention
targeting diet, physical activity, smoking and adherence to
medication (n=239). Measurements were carried out at base-
line, 1 year and 5 years in outpatient clinical research facilities
by trained staff following standard operating procedures. We
used 1 year and 5 year follow-up data (hereafter referred to as
baseline and follow-up) as objectively measured physical ac-
tivity was measured only at these time points. As there were
no between-group differences in health behaviours or CVD
risk factors at 1 year [18], the trial arms were pooled and a
cohort analysis was conducted. We excluded individuals who:
(1) did not attend for follow-up (n=80); (2) did not have
complete data for physical activity and sedentary time at both
baseline and follow-up (n=49); and (3) did not have data for
all cardiometabolic outcomes and covariates (n=41). The final
sample size for our study was 308 participants. All partici-
pants gave written informed consent and ethical approval
was obtained from the Eastern Multi-Centre Research Ethics
Committee (reference number 02/5/54).
Measurement of physical activity, sedentary time and
CRF Free-living physical activity was measured using a com-
bined heart rate and movement sensor (Actiheart, CamNtech,
Cambridge, UK) worn continuously for ≥4 days, as described
elsewhere [19]. A graded treadmill walk test was used to
individually calibrate heart rate [20] and to estimate CRF in
individuals who had at least a 10 min test duration by extrap-
olation of the heart rate/oxygen consumption relationship to
the age-predicted maximum heart rate [21]. A group calibra-
tion equation adjusted for age, sex, β-blockers and sleeping
heart rate was developed and used for the translation of heart
rate into physical activity intensity in participants who did not
complete an individual calibration test. Heart rate data collect-
ed during the free-living period were pre-processed [22] and
the average activity intensity (J min−1 kg−1) was estimated
using a branched equation framework [23]. The resulting
intensity time-series data were summarised into PAEE
(kJ kg−1 day−1), time spent sedentary (h/day), excluding self-
reported sleep, and time spent in MVPA (min/day). Periods of
non-wear were inferred from the combination of non-
physiological heart rate (large Bayesian uncertainty [22])
and periods of inactivity (accelerometry counts of zero) lasting
more than 90 min. Summary estimates were generated while
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minimising diurnal information bias caused by non-wear pe-
riods. Time spent sedentary was defined as a metabolic equiv-
alent of task (MET) value of <1.5 [24] and MVPA as
≥3.0 METs, primarily using the Oxford estimate of resting
metabolic rate to define 1.0 MET [25], and secondarily using
a fixed value of 20.35 J ml O2×3.5 ml O2min
−1 kg−1. MVPA
classified by a higher threshold of 3.5 METs was also inves-
tigated. All individuals included in this analysis had at least
3 days of valid wear time and 8 h of wear time per day.
Measurement of cardiometabolic risk factors and covari-
ates Height and weight were measured with individuals wear-
ing light clothing but no shoes, using a fixed rigid stadiometer
and scale (SECA, Birmingham, UK). Waist circumference was
measured as the mean of two measurements taken with a tape
measure at the midpoint between the lowest point of the rib
cage and the anterior superior iliac crest while standing. Blood
pressure was measured as the mean of three measurements
performed after 10 min of rest while participants were seated
with a cuff placed on their dominant arm at the level of the
heart, using an automated sphygmomanometer (Omron M4,
Milton Keynes, UK). HbA1c was measured in venous samples
using an ion-exchange HPLC (Tosoh Bioscience, Redditch,
UK). Serum HDL-cholesterol and triacylglycerol were mea-
sured using enzymatic techniques (Dade Behring Dimension
Analyzer; Dade Behring, Newark, NJ, USA).
Standardised questionnaires were used to collect informa-
tion on sociodemographic characteristics and lifestyle behav-
iours, including sleep times, smoking status, alcohol con-
sumption and medication use. Alcohol consumption was
reported as units per week. Smoking status was categorised
as current, former or never smoker. Occupational socioeco-
nomic class was categorised as managerial/professional, inter-
mediate or routine/manual based on current or previous occu-
pation. A validated food frequency questionnaire was used to
estimate total daily energy intake [26].
Calculation of the clustered cardiometabolic risk score A
clustered cardiometabolic risk (CCMR) score was constructed
by summing z scores (units of SD from the population mean)
of baseline values for waist circumference, systolic blood
pressure (SBP), HbA1c, the inverse of HDL-cholesterol con-
centration and, due to its non-normal distribution, the natural
log of triacylglycerol concentration, using sex-specific base-
linemeans and SDs (CCMR=[value−mean]/SD), fromwhich
z scores of the follow-up variables were also computed. The
use of a common mean and SD for standardised variables at
two time points ensures that changes in the score can vary
from zero. We divided both by 5, separately, to account for
the number of variables included. Change in the CCMR was
calculated by subtracting the follow-up CCMR from the base-
line CCMR. To examine whether waist circumference was a
mediator of any associations, a second score was made by
excluding waist circumference from the CCMR (denoted
CCMR−WC), thereby allowing waist circumference to be used
as a covariate.
Statistical analysisDescriptive characteristics at baseline and
follow-up were summarised separately for men and women.
Paired t tests, χ2 tests and Wilcoxon signed rank tests were
used to examine differences between individuals’ characteris-
tics at baseline and follow-up. In addition, t tests or χ2 tests
were used to investigate differences between individuals with
and without missing data at both time points. Spearman cor-
relation coefficients were calculated to examine the correla-
tions between the baseline and follow-up values of the phys-
ical activity exposures.
We used multivariable linear regression analyses to
model the associations between baseline PAEE, sedentary
time, MVPA and CRF, and 4 year values of waist circum-
ference, SBP, the natural log of triacylglycerol concentration,
HDL-cholesterol level, HbA1c and CCMR scores. Models
were adjusted for age and sex (model 1), intervention group,
occupational socioeconomic class and baseline smoking sta-
tus, sleep duration, total energy intake, alcohol intake, waist
circumference (except when waist circumference or CCMR
was included as an outcome), use of antihypertensive,
glucose-lowering or lipid-lowering drugs where appropriate
and baseline levels of outcome variables (model 2). To inves-
tigate the independent associations of sedentary time and
MVPA with each outcome, we additionally adjusted MVPA
for sedentary time and vice versa (model 3). Next, we used
multivariable linear regression analyses to examine the asso-
ciations between changes from baseline to follow-up in PAEE,
sedentary time, MVPA and CRF, with changes in CCMR and
its components over the same period. Models were adjusted
for the baseline and follow-up levels of the covariates listed
above as well as the baseline levels of the exposure and out-
come variables. All regression models were analysed with
PAEE, sedentary time, MVPA and CRF as tertiles due to
violation of the assumption of linearity between baseline
physical activity/fitness variables and cardiometabolic risk
variables at follow-up; however, our data met all other
assumptions of linear regression.
We investigated interaction by sex by entering cross-
product terms (i.e. MVPA×sex) with main effects in the
most adjusted multivariable models. After confirming no
effect modification by sex (all p values ≥0.05), except for
the associations between sedentary time and waist circum-
ference and between change in PAEE and change in waist
circumference, we chose to conduct pooled analyses
adjusted for sex.
All statistical analyses were performed using Stata/SE ver-
sion 13.1 (Stata-Corp, College Station, TX). Statistical signif-
icance was set at p<0.05.
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Results
Table 1 shows the characteristics of the study participants
(n=308) at baseline and follow-up, stratified by sex. Themean
age of participants was 61.0 (SD 7.2) years at baseline. Men
had higher PAEE and MVPA at both baseline and follow-up,
compared with women. Between baseline and follow-up,
PAEE decreased among women whereas sedentary time
increased. Among men, MVPA and PAEE decreased from
baseline to follow-up whereas sedentary time increased.
Baseline measures of PAEE were strongly positively correlat-
ed with MVPA (ρ=0.92) and strongly negatively correlated
with sedentary time (ρ=−0.80).MVPA at baseline was strong-
ly negatively correlated with sedentary time at baseline
(ρ=−0.68). Baseline PAEE, sedentary time, MVPA and CRF
measures were moderately correlated with the same measures
at follow-up (ρ=0.61, 0.55, 0.58 and 0.57, respectively).
Compared with participants with complete data at baseline,
women with missing data had a higher BMI and SBP and a
larger waist circumference; men had only a larger waist
Table 1 Characteristics of ADDITION-Plus participants at baseline and follow-up
Men Women
Baseline Follow-up Baseline Follow-up
n 202 202 106 106
Age (years) 60.9±7.2 64.8±7.3** 61.3±7.1 65.1±7.1**
Height (cm) 174.8±6.9 174.2±7.0** 161.4±6.9 160.9±6.8**
Weight (kg) 96.1±16.5 96.3±17.8 83.2±16.0 83.0±16.2
BMI (kg/m2) 31.4±5.0 31.7±5.4 31.9±5.5 32.1±5.6
Waist circumference (cm) 110.8±12.6 110.6±13.3 103.4±12.7 102.2±12.8
SBP (mmHg) 132.2±17.0 132.6±15.7 124.7±17.0 129.0±17.4*
HbA1c (%) 6.66±0.96 6.97±0.95** 6.56±0.85 6.88±0.73**
HbA1c (mmol/mol) 49.3±10.5 52.7±10.4** 48.3±9.3 51.8±8.0**
Triacylglycerol (mmol/l) 1.70 (1.20–2.30) 1.60 (1.20–2.30) 1.60 (1.10–2.20) 1.50 (1.10–2.10)
HDL-cholesterol (mmol/l) 1.11±0.27 1.21±0.30** 1.32±0.30 1.42±0.31**
CCMR −0.004±0.53 −0.01±0.53 0.001±0.55 0.04±0.54
Medication
Glucose-lowering 98 (48.5) 153 (75.7)** 52 (49.1) 68 (64.2)**
Antihypertensive 150 (74.3) 161 (79.7)** 76 (71.7) 79 (74.5)**
Lipid-lowering 154 (76.2) 173 (85.6)** 85 (80.2) 89 (84.0)**
PAEE (kJ kg−1 day−1) 34.5 (22.3–47.6) 29.8 (19.9–40.2)** 26.0 (17.5–34.5) 23.5 (14.4–32.2)**
Sedentary time (h/day) 9.98 (8.18–11.7) 10.46 (9.16–11.86)** 9.61 (8.13–11.21) 10.50 (8.88–12.08)**
MVPA (min/day) 71.1 (37.4–129.4) 63.5 (29.5–110.6)* 47.5 (25.1–88.1) 49.9 (18.6–93.7)
CRF (ml O2kg
−1 min−1)a 36.5±8.0 35.7±8.7 30.0±6.5 32.3±9.7
Sleep duration (h/day) 8.01±1.00 8.19±1.04** 8.73±0.95 8.78±0.84
Total energy intake (kJ/day) 7,430±1,938 7,262±2,603 7,004±1,978 6,801±2,085
Alcohol intake (units/week) 6 (1–14) 4 (0–14) 2 (0–5) 1 (0–5)
Smoking status
Current 24 (11.9) 23 (11.4)** 17 (16.0) 17 (16.0)**
Former 116 (57.4) 114 (56.4) 43 (40.6) 41 (38.7)
Never 62 (30.7) 65 (32.2) 46 (43.4) 48 (45.3)
Occupational socioeconomic classb
Managerial/professional 98 (48.5) – 34 (32.1) –
Intermediate 41 (20.3) – 33 (31.1) –
Routine/manual 63 (31.2) – 39 (36.8) –
Data are mean±SD, median (interquartile range) or n (%)
aCRF data were available for 92 men and 33 women
bOccupational socioeconomic class at study baseline
*p<0.05, **p<0.01 baseline vs follow-up, generated by paired t test for normally distributed data, Wilcoxon signed rank test for non-normally
distributed data and χ2 test for proportions
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circumference (all p≤0.05). At follow-up, women with missing
data had a higher a BMI and SBP, andmen had a higher HbA1c,
compared with participants with complete data (all p≤0.01).
CRF data were present for 125 participants. These individuals
had lower BMI andwaist circumference at baseline and follow-
up (p<0.01) than the rest of the study population. Those with
CRF data also had a higher PAEE and MVPA at both baseline
and follow-up and spent less time sedentary at both time points
(p<0.001).
In adjusted analyses (models 2 and 3), the baseline time
spent sedentary and MVPAwere not predictive of CCMR or
individual cardiometabolic risk factors at follow-up (Table 2).
Unexpectedly, those in the highest tertile for CRF had a
9.03 mmHg (95% CI 3.17, 14.89 mmHg) higher SBP than
those in the lowest tertile. When compared with individuals in
the lowest tertile for PAEE at baseline, those in the highest
tertile had a 0.42% (95% CI 0.12%, 0.73%) higher HbA1c at
follow-up. No other statistically significant associations were
found.
Individuals in the lowest, middle or highest sex-specific
tertiles of change for PAEE, sedentary time, MVPA and
CRF decreased, maintained or increased their levels, respec-
tively, over the 4 years of follow-up (Table 3). The lowest,
middle and highest tertiles of change are therefore referred to
as ‘decreasers’, ‘maintainers’ and ‘increasers’, respectively.
Participants who increased their PAEE and CRF between
baseline and follow-up had greater reductions in CCMR and
waist circumference than decreasers (Table 3). Those who
increased their sedentary time had a 3.20 cm (95% CI 0.84,
5.56 cm) greater increase in waist circumference than
decreasers. Individuals who increased their MVPA had a
6.30 mmHg (95% CI 1.03, 11.58 mmHg) greater reduction
in SBP compared with decreasers. When we removed waist
circumference from the CCMR score to examinemediation by
waist circumference, the association between change in PAEE
and change in CCMR−WC was not significant (Table 3). No
other statistically significant associations were found
(Table 3).
Figure 1 shows the adjusted mean change in CCMR by
tertiles of change in PAEE, sedentary time, MVPA and CRF.
Those who increased their PAEE, MVPA and/or CRF had the
smallest increase in CCMR over the 4 year follow-up (PAEE,
p value for trend [ptrend]=0.01; MVPA, ptrend=0.05; CRF,
ptrend=0.01). Conversely, those who increased their sedentary
time had the greatest increase in CCMR, although this trend
was not statistically significant (ptrend=0.47).
When the associations between baseline sedentary time
and waist circumference at follow-up were stratified by sex,
no associations were observed in men (highest vs lowest
tertiles: −2.33 cm, 95% CI −5.21, 0.54) or women (highest
vs lowest tertiles: −1.61 cm, 95% CI −5.59, 2.37). When
associations between change in PAEE and change in waist
circumference were examined by sex, the association was
not significant in men (increasers vs decreasers: −2.06 cm,
95% CI −4.63, 0.51 cm) but was stronger in women
(increasers vs decreasers: −4.42 cm, 95% CI −7.69,
−1.14 cm; p for interaction=0.10). Use of a fixed intensity
threshold to define MVPA did not change the results except
for a significant inverse association between change in PAEE
and change in waist circumference (−2.25 cm, 95% CI −4.25,
−0.24 cm). Increasing the threshold of time spent in MVPA to
3.5 METs caused the association between change in MVPA
and change in CCMR to become statistically significant,
although the point estimate did not change (increasers vs
decreasers: −0.14, 95% CI −0.25, −0.02). Associations with
the other risk factors remained very similar (data not shown).
Discussion
In this prospective study of men and women with recently
diagnosed type 2 diabetes, we show that individuals who
increased their level of MVPA experienced a large and clini-
cally meaningful reduction in SBP, and those who increased
their PAEE or CRF had clinically significant improvements in
waist circumference and CCMR. We additionally show that
individuals who increased the duration of time spent sedentary
had the greatest increase in waist circumference, independent
of time spent in MVPA and baseline waist circumference.
Baseline values for PAEE, MVPA and CRF were generally
not predictive of cardiometabolic risk factors at follow-up.
Our findings suggest that increasing the amount of time spent
being physically active and decreasing the time spent seden-
tary may be an important strategy for self-management of
diabetes early in the course of the disease.
Important strengths of our study include the prospective,
population-based study design and use of objective measures
of free-living physical activity at two time points, which
enabled us to examine the magnitude of the longer term asso-
ciations between changes in levels of physical activity and time
spent sedentary, and changes in a number of cardiometabolic
risk factors. Additionally, as only a small proportion of individ-
uals were lost to follow-up and physical activity and cardiomet-
abolic risk factor data were available for most individuals at
both time points, our findings are likely to be generalisable to
the original cohort of ADDITION-Plus participants.
Several limitations of our study also warrant discussion. As
our study included a relatively homogenous population of
older white adults, our results may not be generalisable to
younger and more ethnically diverse populations. Although
individuals with complete data did not differ on important
cardiovascular risk factors, they did have a lower BMI and
waist circumference compared with those with incomplete
data. We conducted multiple hypothesis tests so we cannot
exclude chance as an explanation for some of our findings,
especially regarding the observed associations between
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baseline CRF and SBP, and PAEE and HbA1c, neither of
which was replicated in the analyses investigating change.
Finally, although we adjusted our analyses for a
comprehensive range of potential confounders, we cannot
exclude the possibility of residual confounding or confound-
ing by unmeasured or unknown factors.
Table 2 Adjusted associations between baseline physical activity, sedentary time and CRF and cardiometabolic risk factors and CCMR at 4 year
follow-up in the ADDITION-Plus cohort
Model 1 Model 2 Model 3
T1 T2 T3 T1 T2 T3 T1 T2 T3
PAEE (kJ kg−1 day−1)
CCMR Ref −0.10 (−0.28, 0.08) −0.18 (−0.37, 0.00) Ref 0.01 (−0.13, 0.15) −0.03 (−0.18, 0.12)
CCMR−WC Ref −0.03 (−0.22, 0.16) −0.04 (−0.23, 0.16) Ref 0.03 (−0.12, 0.19) 0.02 (−0.15, 0.19)
WC (cm) Ref −4.92 (−9.31, −0.53)* −9.60 (−14.10, −5.11)* Ref −0.31 (−2.54, 1.92) 0.85 (−1.54, 3.23)
TG (mmol/l) Ref −0.04 (−0.23, 0.15) −0.01 (−0.20, 0.18) Ref 0.10 (−0.04, 0.24) 0.03 (−0.12, 0.18)
SBP (mmHg) Ref −2.64 (−7.97, 2.69) −6.46 (−11.91, −1.00)* Ref −3.74 (−8.70, 1.22) −6.79 (−12.14, −1.44)*
HbA1c (%) Ref 0.23 (−0.08, 0.54) 0.35 (0.03, 0.67)* Ref 0.21 (−0.08, 0.49) 0.42 (0.12, 0.73)*
HbA1c (mmol/mol) Ref 2.57 (−0.82, 5.95) 3.84 (0.37, 7.30)* Ref 2.27 (−0.84, 5.39) 4.63 (1.27, 7.98)*
HDL (mmol/l) Ref 0.01 (−0.10, 0.11) 0.02 (−0.09, 0.12) Ref −0.05 (−0.12, 0.02) −0.04 (−0.12, 0.03)
Sedentary time (h/day)
CCMR Ref −0.09 (−0.23, 0.06) 0.09 (−0.06, 0.23) Ref −0.04 (−0.15, 0.07) −0.03 (−0.14, 0.09) Ref −0.03 (−0.15, 0.09) −0.01 (−0.15, 0.13)
CCMR−WC Ref −0.11 (−0.27, 0.04) 0.03 (−0.13, 0.18) Ref −0.05 (−0.17, 0.08) −0.02 (−0.15, 0.11) Ref −0.02 (−0.16, 0.11) 0.02 (−0.14, 0.18)
WC (cm) Ref 0.10 (−3.48, 3.68) 4.20 (0.61, 7.79)* Ref −0.48 (−2.20, 1.24) −1.76 (−3.59, 0.08) Ref −0.69 (−2.57, 1.19) −2.13 (−4.41, 0.14)
TG (mmol/l) Ref −0.03 (−0.17, 0.11) −0.02 (−0.16, 0.13) Ref 0.05 (−0.06, 0.15) −0.03 (−0.14, 0.08) Ref 0.04 (−0.07, 0.16) −0.04 (−0.18, 0.10)
SBP (mmHg) Ref −1.23 (−5.66, 3.20) 2.95 (−1.50, 7.39) Ref −1.56 (−5.56, 2.43) 2.72 (−1.55, 6.99) Ref −2.17 (−6.52, 2.19) 1.66 (−3.59, 6.91)
HbA1c (%) Ref −0.10 (−0.34, 0.13) −0.16 (−0.39, 0.08) Ref −0.13 (−0.33, 0.07) −0.20 (−0.41, 0.02) Ref −0.03 (−0.25, 0.18) −0.01 (−0.28, 0.25)
HbA1c (mmol/mol) Ref −1.13 (−3.69, 1.42) −1.70 (−4.26, 0.86) Ref −1.47 (−3.66, 0.72) −2.13 (−4.47, 0.20) Ref −0.35 (−2.72, 2.02) −0.15 (−3.02, 2.72)
HDL (mmol/l) Ref 0.07 (−0.01, 0.15) −0.03 (−0.11, 0.06) Ref 0.01 (−0.04, 0.07) 0.02 (−0.04, 0.07) Ref 0.01 (−0.05, 0.07) 0.02 (−0.05, 0.09)
MVPA (min/day)
CCMR Ref −0.03 (−0.18, 0.12) −0.07 (−0.22, 0.08) Ref 0.06 (−0.05, 0.17) 0.08 (−0.03, 0.20) Ref 0.09 (−0.03, 0.21) 0.14 (−0.02, 0.29)
CCMR-WC Ref −0.01 (−0.16, 0.15) 0.01 (−0.15, 0.16) Ref 0.07 (−0.06, 0.19) 0.10 (−0.03, 0.23) Ref 0.09 (−0.04, 0.23) 0.15 (−0.03, 0.33)
WC (cm) Ref −1.51 (−5.11, 2.09) −4.89 (−8.57, −1.22)* Ref 0.17 (−1.56, 1.90) 0.98 (−0.81, 2.78) Ref 0.10 (−1.86, 2.06) 0.85 (−1.64, 3.35)
TG (mmol/l) Ref −0.01 (−0.15, 0.14) 0.02 (−0.12, 0.17) Ref 0.05 (−0.05, 0.16) 0.05 (−0.06, 0.16) Ref 0.04 (−0.08, 0.16) 0.02 (−0.13, 0.17)
SBP (mmHg) Ref 1.44 (−3.01, 5.89) −3.54 (−8.08, 1.00) Ref 0.76 (−3.29, 4.81) −2.36 (−6.59, 1.87) Ref 2.70 (−1.82, 7.21) 1.39 (−4.38, 7.17)
HbA1c (%) Ref 0.06 (−0.17, 0.29) 0.24 (0.00, 0.48) Ref 0.11 (−0.09, 0.31) 0.30 (0.09, 0.51)* Ref 0.08 (−0.15, 0.30) 0.23 (−0.06, 0.52)
HbA1c (mmol/mol) Ref 0.66 (−1.90, 3.22) 2.61 (0.00, 5.22) Ref 1.25 (−0.94, 3.43) 3.27 (1.00, 5.53) Ref 0.86 (−1.61, 3.32) 2.53 (−0.62, 5.67)
HDL (mmol/l) Ref 0.05 (−0.03, 0.14) 0.02 (−0.06, 0.11) Ref 0.00 (−0.05, 0.06) −0.03 (−0.09, 0.02) Ref 0.03 (−0.06, 0.12) −0.04 (−0.12, 0.04)
CRF (ml O2kg
−1 min−1)a
CCMR Ref 0.14 (−0.08, 0.35) −0.05 (−0.27, 0.17) Ref 0.07 (−0.09, 0.23) 0.05 (−0.12, 0.21)
CCMR−WC Ref 0.18 (−0.05, 0.41) 0.05 (−0.18, 0.28) Ref 0.10 (−0.08, 0.28) 0.11 (−0.08, 0.30)
WC (cm) Ref −0.34 (−5.62, 4.93) −5.61 (−11.02, −0.19)* Ref 0.10 (−2.47, 2.66) −0.54 (−3.26, 2.19)
TG (mmol/l) Ref −0.01 (−0.21, 0.20) −0.06 (−0.27, 0.15) Ref 0.06 (−0.09, 0.22) 0.05 (−0.12, 0.22)
SBP (mmHg) Ref 11.05 (4.91, 17.19)* 6.29 (−0.02, 12.60) Ref 10.61 (5.01, 16.21)* 9.03 (3.17, 14.89)*
HbA1c (%) Ref −0.03 (−0.43, 0.38) −0.03 (−0.45, 0.39) Ref −0.19 (−0.52, 0.13) −0.06 (−0.40, 0.28)
HbA1c (mmol/mol) Ref −0.31 (−4.75, 4.14) −0.34 (−4.91, 4.23) Ref −2.12 (−5.64, 1.40) −0.63 (−4.36, 3.09)
HDL (mmol/l) Ref −0.05 (−0.18, 0.08) 0.00 (−0.13, 0.14) Ref −0.01 (−0.10, 0.08) 0.03 (−0.07, 0.12)
Data are unstandardised regression coefficients and 95% CI
Model 1: adjusted for age and sex
Model 2: model 1+intervention group, occupational socioeconomic class, smoking status, sleep duration, total energy intake, alcohol intake and WC
(except whenWCor CCMR are outcomes). SBP additionally adjusted for antihypertensive drugs at baseline. HbA1c adjusted for glucose-lowering drugs
at baseline. HDL-cholesterol adjusted for lipid-lowering drugs at baseline. CCMR adjusted for all three classes of drugs at baseline
Model 3: model 2+MVPA (when examining sedentary time) or sedentary time (when examining MVPA)
CCMR was constructed by summing sex-specific values for WC, SBP, HbA1c, the inverse of HDL and the natural log of TG, using sex-specific means
and SDs ((CCMR=[value−mean]/SD)/5)
a n=125
*p<0.05
T1–T3, tertiles 1–3; Ref, Reference; WC, waist circumference; TG, triacylglycerol
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Table 3 Adjusted associations between change in physical activity, sedentary time and CRF and change in cardiometabolic risk factors and CCMR over 4 years in the ADDITION-Plus cohort
Model 1 Model 2 Model 3
Decreasers Maintainers Increasers Decreasers Maintainers Increasers Decreasers Maintainers Increasers
PAEE (kJ kg−1 day−1)
CCMR Ref −0.05 (−0.16, 0.07) −0.18 (−0.30, −0.07)* Ref −0.06 (−0.18, 0.06) −0.17 (−0.29, −0.04)*
CCMR−WC Ref −0.02 (−0.15, 0.11) −0.17 (−0.31, −0.04)* Ref 0.00 (−0.13, 0.13) −0.10 (−0.24, 0.04)
WC (cm) Ref −1.76 (−3.47, −0.06)* −2.77 (−4.48, −1.06)* Ref −2.05 (−3.93, −0.17)* −2.84 (−4.84, −0.85)*
TG (mmol/l) Ref 0.13 (−0.13, 0.39) −0.07 (−0.33, 0.19) Ref 0.12 (−0.14, 0.39) −0.06 (−0.34, 0.22)
SBP (mmHg) Ref −2.67 (−7.21, 1.87) −3.36 (−7.91, 1.19) Ref −1.44 (−5.78, 2.90) −2.22 (−6.84, 2.39)
HbA1c (%) Ref −0.07 (−0.31, 0.17) −0.20 (−0.44, 0.04) Ref −0.01 (−0.23, 0.21) −0.04 (−0.27, 0.19)
HbA1c (mmol/mol) Ref 0.77 (−1.85, 3.39) 2.23 (−0.39, 4.86) Ref 0.12 (−2.30, 2.55) 0.43 (−2.12, 2.98)
HDL (mmol/l) Ref −0.01 (−0.07, 0.04) 0.04 (−0.01, 0.10) Ref −0.02 (−0.08, 0.04) 0.01 (−0.05, 0.08)
Sedentary time (h/day)
CCMR Ref 0.12 (0.01, 0.24)* 0.08 (−0.03, 0.20) Ref 0.12 (0.00, 0.23) 0.09 (−0.04, 0.22) Ref 0.09 (−0.03, 0.21) 0.04 (−0.11, 0.18)
CCMR−WC Ref 0.12 (−0.02, 0.25) 0.05 (−0.08, 0.18) Ref 0.06 (−0.06, 0.19) −0.00 (−0.15, 0.14) Ref 0.03 (−0.10, 0.16) −0.06 (−0.23, 0.10)
WC (cm) Ref 1.90 (0.20, 3.61)* 2.74 (1.03, 4.45)* Ref 2.31 (0.53, 4.09)* 3.32 (1.28, 5.35)* Ref 2.25 (0.38, 4.12)* 3.20 (0.84, 5.56)*
TG (mmol/l) Ref 0.02 (−0.23, 0.28) 0.02 (−0.24, 0.28) Ref −0.02 (−0.27, 0.24) −0.06 (−0.36, 0.23) Ref −0.02 (−0.29, 0.25) −0.07 (−0.40, 0.27)
SBP (mmHg) Ref 1.96 (−2.59, 6.52) −0.28 (−4.84, 4.28) Ref −0.36 (−4.52, 3.79) −1.17 (−5.93, 3.59) Ref −1.71 (−6.04, 2.62) −3.98 (−9.43, 1.46)
HbA1c (%) Ref 0.07 (−0.17, 0.31) 0.08 (−0.16, 0.33) Ref 0.09 (−0.12, 0.30) 0.09 (−0.15, 0.34) Ref 0.07 (−0.16, 0.29) 0.04 (−0.24, 0.32)
HbA1c (mmol/mol) Ref −0.73 (−3.37, 1.90) −0.92 (−3.56, 1.72) Ref −0.99 (−3.31, 1.33) −1.02 (−3.70, 1.65) Ref −0.72 (−3.15, 1.71) −0.46 (−3.53, 2.61)
HDL (mmol/l) Ref −0.04 (−0.10, 0.02) −0.01 (−0.07, 0.04) Ref −0.03 (−0.08, 0.03) 0.01 (−0.06, 0.07) Ref −0.02 (−0.08, 0.04) 0.02 (−0.06, 0.09)
MVPA (min/day)
CCMR Ref −0.03 (−0.14, 0.09) −0.15 (−0.26, −0.03)* Ref 0.01 (−0.12, 0.13) −0.12 (−0.24, 0.00) Ref −0.00 (−0.13, 0.12) −0.14 (−0.29, 0.00)
CCMR−WC Ref −0.01 (−0.15, 0.12) −0.14 (−0.28, −0.01)* Ref 0.02 (−0.11, 0.16) −0.08 (−0.22, 0.06) Ref −0.00 (−0.14, 0.14) −0.13 (−0.29, 0.03)
WC (cm) Ref −0.89 (−2.61, 0.83) −2.10 (−3.82, −0.37)* Ref −0.58 (−2.56, 1.40) −1.82 (−3.78, 0.14) Ref −0.23 (−2.29, 1.83) −1.02 (−3.36, 1.33)
TG (mmol/l) Ref 0.05 (−0.21, 0.31) −0.04 (−0.30, 0.22) Ref 0.09 (−0.18, 0.37) −0.04 (−0.31, 0.24) Ref 0.11 (−0.18, 0.39) −0.00 (−0.33, 0.32)
SBP (mmHg) Ref −1.03 (−5.57, 3.51) −3.99 (−8.54, 0.56) Ref −1.48 (−5.97, 3.01) −3.23 (−7.71, 1.26) Ref −2.89 (−7.53, 1.75) −6.30 (−11.58, −1.03)*
HbA1c (%) Ref −0.12 (−0.36, 0.12) −0.14 (−0.39, 0.10) Ref −0.01 (−0.23, 0.22) −0.03 (−0.26, 0.20) Ref −0.01 (−0.25, 0.23) −0.04 (−0.31, 0.24)
HbA1c (mmol/mol) Ref 1.29 (−1.34, 3.92) 1.58 (−1.06, 4.22) Ref 0.06 (−2.44, 2.56) 0.35 (−2.14, 2.84) Ref 0.08 (−2.53, 2.70) 0.40 (−2.57, 3.36)
HDL (mmol/l) Ref −0.03 (−0.08, 0.03) 0.03 (−0.03, 0.09) Ref −0.03 (−0.09, 0.03) 0.01 (−0.05, 0.07) Ref −0.03 (−0.10, 0.03) 0.00 (−0.07, 0.08)
CRF (ml O2kg
−1 min−1)a
CCMR Ref −0.07 (−0.23, 0.08) −0.21 (−0.36, −0.05)* Ref −0.07 (−0.24, 0.10) −0.23 (−0.40, −0.05)*
CCMR−WC Ref −0.04 (−0.23, 0.14) −0.21 (−0.39, −0.02)* Ref 0.03 (−0.17, 0.22) −0.12 (−0.33, 0.08)
WC (cm) Ref −2.45 (−4.91, −0.00)* −2.64 (−5.12, −0.17)* Ref −2.78 (−5.48, −0.08)* −3.79 (−6.62, −0.96)*
TG (mmol/l) Ref −0.09 (−0.50, 0.32) −0.39 (−0.80, 0.02) Ref 0.14 (−0.27, 0.55) −0.11 (−0.53, 0.32)
SBP (mmHg) Ref −5.08 (−11.66, 1.51) −8.56 (−15.19, −1.92)* Ref −1.07 (−7.04, 4.90) −5.34 (−11.57, 0.90)
HbA1c (%) Ref 0.08 (−0.27, 0.42) −0.09 (−0.44, 0.26) Ref 0.08 (−0.27, 0.42) 0.10 (−0.26, 0.45)
HbA1c (mmol/mol) Ref −0.86 (−4.63, 2.90) 1.01 (−2.79, 4.81) Ref −0.84 (−4.61, 2.93) −1.05 (−4.91, 2.81)
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Table 3 (continued)
Model 1 Model 2 Model 3
Decreasers Maintainers Increasers Decreasers Maintainers Increasers Decreasers Maintainers Increasers
HDL (mmol/l) Ref −0.02 (−0.11, 0.06) 0.02 (−0.07, 0.10) Ref 0.00 (−0.10, 0.09) 0.04 (−0.06, 0.13)
Data are unstandardised regression coefficients and 95% CI
Model 1: adjusted for age at baseline and sex
Model 2: model 1+intervention group, occupational socioeconomic class at baseline, baseline values of the respective exposure and outcome and change in age, smoking status, sleep duration, total energy
intake, alcohol intake, WC and medication use (antihypertensive, lipid-lowering and glucose-lowering)
Model 3: model 2+change in MVPA (when examining sedentary time) or change in sedentary time (when examining MVPA)
Change by tertile (mean±SD):
PAEE (kJ kg−1 day−1 ): decreasers, −20.19±10.30; maintainers, −4.1±3.08; increasers, 10.04±7.69
Sedentary time (h/day): decreasers, −1.76±1.24; maintainers, 0.66±0.57; increasers, 2.93±1.28
MVPA (min/day): decreasers, −73.90±52.90; maintainers, −5.23±9.85; increasers, 54.44±41.75
CRF (ml O2kg
−1 min−1 ): decreasers, −8.05±6.19; maintainers, −0.13±2.20; increasers, 8.49±5.64
CCMR was constructed by summing sex-specific values for WC, SBP, HbA1c, the inverse of HDL and the natural log of TG, using sex-specific means and SDs ((CCMR=[value−mean]/SD)/5)
a n=125
*p<0.05
Ref, reference; WC, waist circumference; TG, triacylglycerol
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We used objective measures of physical activity and sed-
entary time, which allowed us to more accurately assess phys-
ical activity compared with self-report measures. By using
individually calibrated combined heart rate and movement
monitoring, we were able to include non-ambulatory activities
such as cycling, which would be difficult to detect if we had
used only a waist-mounted accelerometer. However, piezo-
electric accelerometers worn on the torso are not ideally suited
to detect transitions between sitting and standing [27], which
may have different physiological effects [28]. Our exposure
measure is therefore unlikely to be very sensitive to differ-
ences in posture, and we also did not examine breaks in sed-
entary time, which have been shown to be associated with
waist circumference [10, 29].
We adjusted for MVPA in the analyses of sedentary time
and vice versa when examining intensity associations, so were
able to investigate the independent contributions of these
exposures. Although the meanMVPA in our study population
may be considered high compared with that observed in other
studies, this is likely to be due to how physical activity was
measured in our study: we used an epoch frequency of 30 s,
enabling relatively short periods of activity to be detected, and
we used a relative definition of 3METs, which averaged 168.2
and 149.8 J min−1 kg−1 for men and women, respectively.
Furthermore, we were able to capture non-ambulatory physi-
cal activities that may not have been detected in studies using
accelerometers alone. Our findings of a relatively high amount
of accumulated MVPA is similar to what Hansen et al
observed when using the same physical activity monitor as
we used [30].
Previous cross-sectional studies have found inconsistent
associations between objectively measured physical activity
and sedentary time with cardiometabolic risk factors in the
general adult population [9, 12, 14, 31] and in populations at
high risk of diabetes [11, 32]. In a cross-sectional study of the
ADDITION-Plus cohort at 1 year, we previously showed that
CRF and PAEE were inversely associated with CCMR and
waist circumference [33]. In a cross-sectional analysis of a
different cohort of individuals with newly diagnosed diabetes,
sedentary time was found to be positively associated with
waist circumference; however, the authors found no associa-
tions between sedentary time at baseline or change in seden-
tary time over 6 months of follow-up and any of the measured
cardiometabolic risk factors at 6 months follow-up [29].
Few prospective studies have examined associations
between objectively measured physical activity, fitness or sed-
entary time and cardiometabolic risk [29, 15, 34–37]. Ekelund
et al, in a general adult population (n=258), found that an
increase in PAEE over 5 years of follow-up was associated
with reductions in fasting glucose, insulin, triacylglycerol and
CCMR [15]. In a large international, multicentre study includ-
ing 4,345 older men and women with impaired glucose toler-
ance, baseline ambulatory activity and change in ambulatory
activity, assessed by pedometer, were both inversely associat-
ed with risk of cardiovascular events over 6 years of follow-up
[37]. In a sample of 321 individuals with a family history of
diabetes, an increase in total daily activity, measured by
accelerometry, and aerobic fitness were associated with
decreases in CCMR score after 1 year, although the change
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Fig. 1 Adjusted mean change in physical activity, sedentary time and
CRF and change in CCMR, by tertiles of change in physical activity. Data
are means and 95% CIs adjusted for age, sex, intervention group, occu-
pational socioeconomic class, clustered metabolic risk score and physical
activity variable at baseline and change in age, alcohol consumption,
energy intake, smoking status, sleep duration and medication use. (b)
and (c) are additionally adjusted for change in MVPA and change in
sedentary time, respectively. ptrend: (a) 0.009; (b) 0.47; (c) 0.05; (d) 0.01
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in PAEE measured using individually calibrated heart rate
monitoring was not [34]. In the same population, but with
6 years of follow-up data, increases in MVPA were found to
be associated with reductions in waist circumference and
CCMR, while increases in time spent sedentary were associat-
ed with increases in waist circumference and CCMR [36].
However, these associations were attenuated following mutual
adjustment for time spent sedentary and in MVPA. In addition,
Lahjibi et al, in a general adult population, found no associa-
tions between sedentary time, measured by accelerometry, and
cardiovascular risk factors over 3 years of follow-up [38].
The potential consequences of spending too much time sed-
entary has become an area of increased research focus. The
physiological effects of prolonged sedentary time may be dis-
tinct from, and therefore independent of, those underlying
physical activity [28]. As themajority of the woken day is spent
sedentary, especially among individuals close to retirement age
(the mean age of our population at follow-up was 65 years),
there are clear windows of opportunity for increasing activity,
the benefits of which can lead to clinically important improve-
ments in cardiometabolic risk. Although the effects of the tran-
sition to retirement on physical activity levels remain unclear
[39], small lifestyle changes such as replacing a short car jour-
ney with walking or cycling and taking the stairs instead of
using an elevator present clear opportunities to counteract the
potential decline in physical activity and increase in sedentary
time due to retirement [40].
Conclusion
In this population of older adults with diabetes, increases in
PAEE and CRF over 4 years of follow-up were associated with
reductions in CCMR, and increases in MVPAwere associated
with reductions in SBP, whereas increases in sedentary time
were associated with increases in waist circumference.
Further follow-up is necessary to establish whether changes
in physical activity predict CVD events. Nevertheless, these
data highlight the importance of encouraging patients to in-
crease their physical activity and decrease their sedentary time.
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